Prevention is safer, faster and cheaper than cure.

Peezy Midstream

Peezy Midstream takes the guesswork out of diagnosis and treatment.

Right-first-time urine analysis and targeted treatment need the right specimen. Peezy makes midstream mainstream.

Giovanna Forte,
CEO, Forte Medical

Urine is one of the most important carriers of cancer biomarkers, bacteria, protein, glucose and more, all of which can raise the alarm to serious illness. If left undiagnosed these conditions can become far more difficult and costly to treat.

Yet there is no gold standard for urine collection anywhere in the world, leaving patients vulnerable to failed diagnosis and failed treatment:

  • 50% AMR incidences have a urinary source
  • 47% Gram-negative blood infections caused by urinary tract infection
  • 22% Average unreliable urine specimens (USA and UK)

Forte Medical has developed world-first technology that delivers super-accurate urine specimens and right-first-time preventative urine-based medicine. Peezy Midstream reduces specimen contamination to just 1-2.5%, delivering diagnostic integrity, targeted treatment and huge financial savings. See our animated instructions for use.

We are now developing The Specimen Collection, a portfolio of devices designed to help with identification of early stage cancers including prostate, testicular, cervical, bladder, kidney and more. Smart digital solutions are planned for each product.

Peezy Midstream is MHRA registered, FDA listed and patented.